Malnutrition poses a great risk to human life. The World Health Organization (WHO) states that malnutrition forms the reason for 11 percent of the diseases prevailing across the world. Moreover, the rising occurrence of malnutrition can lead to the emergence of problems such as food insecurity and political unrest. Therefore, the increasing incidence coupled with the rising concerns is promoting the uptake of parental nutritional.
This report serves with a 360-degree view of the global parental nutrition market by providing insights into all important aspects, including trends and opportunities, nutrient type and regional segmentation, and vendor landscape.
From the geographical standpoint, the report classifies the global parenteral nutrition market into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America will continue to be the frontrunner in the global arena until 2023. The growth of the region can be attributed to the favorable reimbursement scenario. The U.S. and Canada will be key revenue contributors to the region. The expanding pool of patients suffering from cancer and diabetes and growing geriatric population are triggering the adoption of parental nutrition in these countries. Furthermore, the increasing efforts by regional players to expand their operations within Canada is working in favor of the North America parenteral nutrition market.
Request for the Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3611
On the other hand, Asia Pacific is anticipated to be the most promising region, progressing at a noteworthy 7.0% CAGR during the review period. The flourishing growth of the pharmaceutical industry, particularly in countries such as Taiwan, Thailand, Indonesia, Singapore, China, and India, is augmenting the growth of the region. Besides this, the mounting cases of preterm birth, resulting in increased cases of malnutrition is also contributing to the growth of the region.